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ASSESSMENT OF METHYLPHENIDATE SENSITIZATION USING
A TWO-LEVER DRUG DISCRIMINATION PROCEDURE

Ann Marie Heidema, M.A.
Western Michigan University, 2000

The current study examined the effects of methylphenidate (MP)
pre-exposure on the acquisition of cocaine discrimination in rats.
Sixteen male Sprague-Dawley rats were administered either 10 mg/kg
MP or saline for five consecutive days. Following this pre-treatment
phase, animals were trained to discriminate 10 mg/kg cocaine
hydrochloride from saline using a two-lever fixed-ratio 20 (FR20)
schedule of food reinforcement.

Acquisition of cocaine discrimination,

as indicated by the number of sessions to criterion, did not differ
significantly between the two-pre-treatment groups (MP = 35.5 ± 2.4;
SAL = 31.6 ± 2.3). Stimulus generalization tests were conducted with
cocaine and methylphenidate using cumulative dosing procedures. The
dose response curves for both methylphenidate and cocaine were not
significantly

different

between

the

two

pretreatment

groups.

Methylphenidate completely substituted for cocaine at doses of 4.0
mg/kg and 8.0 mg/kg in both treatment groups.
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INTRODUCTION
The Relationship Between ADHD and SUD
The relationship between Attention-deficit hyp eractivity disorder
(ADHD) and substance use disorder (SUD) is a multi-faceted dilemma that
has been discussed extensively in the literature. Studies have shown the co
occurrence of ADHD and SUD to be larger than would be expected by chance
(Biderman, Wilens, Mick, Milberger, Spencer, and Faraone, 1995; Levins and
Kluber, 1995).

Several studies indicate that ADHD subjects have a

significantly higher lifetime rate of drug and alcohol abuse or dependence
when compared to non-ADHD controlds (Biederman, 1995).

Schubiner,

Tzelepis, Isaacson, Warbasse, Zacharak, and Musiel (1995) found an increased
incidence of ADHD in populations of alcoholics and other drug abusers.
There are multiple factors that contribute to this relationship, including
variations in assessments, diagnostic criteria, and the reliability of the report.
One hypothesis regarding the significant co-occurrence of ADHD and SUD is
a self-medication hyp othesis.
This hyp othesis postulates that individuals use psychoactive
substances in an attempt to minimize the experience of psychiatric symptoms.
The rationale is that since cocaine abusers have a high incidence of co-morbid
SUD and ADHD, they may abuse cocaine as a way of self- medicating.
Further evidence to support this hyp othesis is that cocaine has
pharmacological actions that are similar to those of methylphenidate (MP)
1
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(Levin and Kluber, 1995; Volkow, Ding, Fowler, Wang, Logan, Gatley,
Dewey, Ashby, Liebermann, Hitzemann, and Wolf, 1995).

Recent studies

confirm that individuals with ADHD symptoms persisting into adulthood are
at greater risk for having a substance use disorder. Levin and Kluber (1995)
found that 35% of cocaine abusers seeking treatment had a history of
childhood ADHD and approximately 15% of cocaine abusers seeking
treatment may have adult ADHD. Sustained-release methylphenidate in
daily doses up to 80 mg, have been successful in reducing symptoms such as
cocaine craving, and cocaine use among cocaine abusers with ADHD {Levin,
Evans, McDowell, and Kleber, 1998; Grabowski, Roache, Schmitz, Rhoades,
Creson, and Korszun 1996). However, further investigation is needed to
support the use of MP for reducing cocaine dependence.
In efforts to delineate the relationship between stimulant use and
abuse, Biderman, Wilens, Mick, Spencer, and Faraone (1999) address the risk
for SUD associated with previous exposure to psychotropic medication in a
longitudinal study of boys with ADHD.

They found unmedicated subjects

with ADHD were at a significantly increased risk for SUD when compared
with non-ADHD controls, as well as with medicated ADHD subjects.
Still the idea that pharmacotherapy increases the risk for SUD persists
in diagnostic literature and in the popular press (Altman, Everitt, Glautier,
Markou, Nutt, Oretti, Phillips, and Robbins, 1996).

Although clinical

investigations show stimulant medication to be particularly effective in
treating the behavioral aspects of ADHD, controversy surrounding the use of
stimulant medication in the treatment of children endures. Currently an
estimated 1.29 million children are being treated with psychostimulants
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Gulien, 1997). In 90% of diagnosed ADHD cases the prescribed treatment is
methylphenidate hydrochloride Gulien, 1997; Goldman, Genel, Benzman, &
Slanetz, 1998). Although this treatment is effective, there is concern regarding
the pharmacological treatment of children with a stimulant that possesses
commonalties with drugs of abuse such as cocaine and cl-amphetamine.
Although MP is self-administered by animals (Neilsen, Duda, Mokler, &
Moore, 1984; Risner & Jones, 1976; Johanson & Schuster; 1975) and is
reportedly abused by humans (Fulton & Yates, 1988; Dakis & Gold, 1990;
Haglund & Howerton, 1982) more research is required to elucidate the effects
of methylphenidate treatment in subjective experience of stimulants.
Sensitization to Drug Effects
Sensitization is a progressive increase in a drug effect with repeated
administration or rather a persistent hyp ersensitivity to an effect of the drug
as a consequence of past history. Sensitization is operationally defined as a
shift in a dose-effect function to the left following repeated drug
administration. The repeated administration of psychoactive compounds
often results in modification of the subject's behavioral responses, frequently
making the organism more sensitive to the effects of the drug. Schenk and
Partridge (1997) reviewed the literature on the effects of stimulant pre
exposure on self-administration and found reports that repeated exposure to
stimulants sensitizes subjects to the reinforcing properties of subsequent
exposures. However, Schenk and Partridge (1997) also found reports that
repeated exposure produces tolerance to the reinforcing effects of subsequent
exposures. Tolerance can be described as a shift in the dose effect function to
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the right, illustrating that higher doses are required to produce the same
effect. Extended daily self-administration of cocaine produces tolerance to
the reinforcing effects of cocaine in rats, however, intermediate drug
exposure has been shown to produce sensitization to the reinforcing effects of
cocaine in a variety of behavioral assays ( Altman, et al., 1996).
Yet there is much debate surrounding the topic of sensitization due to
difficulties inherent in replication of the phenomenon. This may be due to the
fact that only certain treatment regimens are effective. There are numerous
methodological factors to consider, such as the drug used, dose, time course,
route, and behavioral measures.

Unfortunately, there has been little

systematic research on the specific parameters required to produce the
desired result. There is also debate regarding the use of appropriate
behavioral measures for sensitization. Robinson and Berridge (1993) argue
that measures of locomotion are often not good indicators of a profound
sensitization phenomenon, because stimulant-induced locomotion does not
produce a strictly linear dose-effect function.
The majority of previous studies have examined the effects of
sensitization using the behavioral measures of locomotion or self
administration. Repeated administration of stimulants (i.e. amphetamine,
meth-amphetamine, methylphenidate and caffeine) produces long-lasting
behavioral effects (Gayton, al-Rahim, Swann, and Dafny, 1997; Horgan, Giles,
and Schenk, 1990; Kolta, Shreve, and Uretsky, 1985). There is evidence that
sensitizing regimens, enhance the acquisition of drug taking behavior in rats
(Valdez and Schenk, 1994; Horger, Shelton, and Schenk, 1990; Schenk,
Worley, McNamara, and Valadez, 1996). For example, Valadez and Schenk
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assessed the effects of amphetamine (2.0 mg/kg, i.p., for 9 consecutive days)
pre-exposure on the subsequent reinforcing effects of cocaine and found that
latency to acquire reliable cocaine self-administration was shorter in the
amphetamine pre-exposed animals than in the saline pre-exposed subjects.
They also noted the sensitizing effects of amphetamine exposure persisted for
45 days following the treatment
Furthermore, sensitization has also shown to influence locomotor
behavior. McNamara, Davidson, and Schenk (1993) examined a comparison
of the locomotor-activating effects of acute and chronic exposure to
methylphenidate or amphetamine. They reported that acute exposure to
methylphenidate (5.0, 10.0, or 20.0 mg/kg) and amphetamine (0.5, 1.0, 2.0,
and 4.0 mg/kg) produced a dose-dependent increase in horizontal activity
with cocaine reinstatement (McNamara et al., 1993).

The 20.0 mg/kg

methylphenidate group exhibited smaller increases in activity with repeated
doses; the authors' state that this may suggest chronic exposure produces
tolerance. In another study, MP sensitization (2.5 mg/kg, for five consecutive
days) produced augmented locomotor effects to challenge doses of MP (0.6
and 2.5 mg/kg) (Gayton, Sahim, Swarm, and Dafny, 1997). Kolta, Shreve,
and Uretsky (1985) found that after rats were chronically pretreated with MP
(20 mg/kg, i.p., for five consecutive days) the stereotypical behavioral
response to challenge doses of amphetamine was significantly enhanced.
The contention that early exposure to stimulants may be associated
with potential for abuse has not yet been fully examined. Given the growing
population of children with ADHD currently receiving psychomotor
stimulants, further study of stimulant exposure as a factor for SUD risk is
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required. Although the drug effects may be dependent on the clinical regime
of treatment, the potential for stimulant sensitization poses an interesting
question regarding risk for SUD. A clinically relevant experiment conducted
by Brandon, Marinelli, & White (1999) recently examined the effects of cross
sensitization to cocaine following repeated methylphenidate exposure in
juvenile rats. They found MP pre-exposure (10 mg/kg, i.p. for seven
consecutive days) significantly enhanced the acute effects of cocaine on
locomotor and rearing behaviors.
Previous drug exposure can have profound effects on behavior,
enhancing not only the reinforcing effects of drugs as illustrated by non
human self-administration, but also by the behavioral activating effects of
drug reinstatement as illustrated in the by the locomotor studies. However,
the question of how previous exposure to stimulants affect the subjective
experience remains. The reinforcing subjective effects of drugs as measured
by self-report in humans, correlates with abuse potential of that drug.
Development of a model that addresses the issue of drug history and
subjective drug experience may have serious implications for clinical
populations.
The Drug Discrimination Procedure
Drug discrimination is a common model for evaluating the 'subjective'
effects of drugs. Discriminative stimulus effects of drugs are the properties of
drugs, which act as cues directing behavior. The correlation between patterns
of cross-generalization in non-human drug discrimination experiments and
similarities in subjective effects in human subjects serve as powerful evidence
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to support this theory {Altman et al, 1996; Stolerman, 1993). This work is
distinguished from other branches of behavioral pharmacology because it is
not based on observations of how drugs influence an ongoing baseline of
behavior that is stabilized in the absence of drug. In this model, drugs serve
as stimuli. Discriminative stimulus effects of drugs in non-humans refer to
the capacity of animals to use drug (or placebo) states as discriminative cues
to respond to reinforcement. Discriminative stimulus effects may enhance our
understanding of drug dependence, for it is widely accepted that the
subjective effects of drugs contribute to the extent to which they are abused.
Relatively few studies directly address the role of previous drug
history as a determination of discriminative response. In a study conducted
by Ator and Giffiths (1993), previous drug history was found to affect the
dose response curve in generalization tests. History of self-administration of
the benzodiazepine, midazolam, in baboons produced a shift to the left in
generalization tests

when compared to curves generated before self

administration training, illustrating an enhanced drug sensitivity to low
doses following exposure. The data suggest that sensitivity to the
discriminative stimulus effects of a drug can be modulated by previous
experience with that drug. This study was essential in expanding
understanding of the drug history on stimulus properties. However, this
study was conducted with only two subjects, and was subject to procedural
interaction between discrimination and self-administration assays. This study
illustrates the importance of investigating the effects of drug history on dose
response functions.
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The Purpose of the Present Study
The primary goal of the present study was to assess the role of
methylphenidate exposure in the discriminative stimulus properties of
cocaine. The effects of pretreatment with methylphenidate on acquisition of
cocaine discrimination, terminal accuracy across training sessions, latency to
the first fixed ratio (FR), and generalization testing with both cocaine and
methylphenidate were examined.
A secondary goal of this study was to examine the usefulness of the
drug discrimination assay as a tool for studying sensitization. Implications
for the clinical relevance of methylphenidate exposure to cocaine sensitivity
are also discussed.
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METHODS
Subjects
Sixteen male Sasco Sprague-Dawley rats (Charles River Breeding
Colony, Portage, MI) approximately five weeks old at the beginning of the
study were used as subjects. The animals were individually housed in acrylic
cages with celludry bedding, in a colony maintained on a 12 hour light/ dark
cycle (0700 to 1900) and at a relatively constant temperature (20-22 ° C) and
humidity (50-65%). Water was provided in the home cages ad libitum, and
food was restricted to maintain the animals at 85% of their free-feeding body
weights. The animals were maintained in accordance with the general
principles of animal husbandry outlined by the National Institutes of Health
and the experimental protocol was reviewed and approved by the
Institutional Animal Care and Use Committee of Western Michigan
University (see Appendix A).
Apparatus
Training and test sessions were conducted in eight standard operant
chambers (MED Associates Inc., Georgia, VT), housed in sound and light
attenuating shells, which provide ventilation and masking noise. The
experimental chambers were equipped with an overhead house light, a food
pellet dispenser and three retractable levers. MED-PC for windows (MED
Associates Inc., Georgia, VT) instrumentation and software were used to
control the experimental events and data collection. Dustless precision 45 mg
pellets (Bioserv, Frenchtown, NJ) severed as the food reinforcement.
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Drugs
Methylphenidate-hydrochloride was administered intraperitoneally
at a dose of 10 mg/kg to eight rats during a pre-exposure period (see below).
A dose of 10 mg/kg cocaine was used during discrimination training. Doses
were calculated based on the salt. The drug was dissolved in sterile 0.90%
saline and injected intraperitoneally. Drugs were obtained from the National
Institute of Drug Abuse (NIDA, Bethesda, MD).
Training Procedures
Lever Press Training
Animals were auto-shaped to lever press on the center lever for food
reinforcement prior to any drug exposure. In the first session, no levers were
present, and food was delivered on a fixed time 60-sec interval (FT 60)
schedule for two 35 minute sessions, to pair the sound of the pellet drop with
food delivery. The center lever was then presented and lever presses were
reinforced on a continuous reinforcement schedule for a 20 minute period.
Following acquisition of the lever pressing response, 20 minute training
sessions were conducted where lever pressing was reinforced on a fixed ratio
(FR) schedule that gradually incremented from a FR 1 to a FR 20, until
responding was stable on the FR 20 resetting schedule.
Methylphenidate Exposure
Once lever pressing behavior was acquired and responding was
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maintained on a FR 20 schedule of food reinforcement, the animals were
randomly assigned to one of two groups. Control for high and low
responding rates were taken into account. Subjects with rates of greater than
.50 responses per second were deemed high responders and subjects with
rates of less than .50 responses per second were deemed low responders.
High and low responders were equally distributed to each of two treatment
groups. One group of eight rats received an intraperitoneal (i.p.) injection of
MP (lOmg/kg) and one group of eight rats received saline injections once per
day for five consecutive days in their home cage (Brandon, Marinelli, and
White, 1999).
Discrimination Training
Following the pre-exposure procedure, discrimination training
began. Fifteen minutes prior to the onset of each training session, the rats
were administered a single intraperitoneal (i.p.) injection of cocaine (10
mg/kg) or saline. Animals received an average of three drug injections per
week, with no more than two consecutive days of drug injections. Drug or
saline conditions were presented in a semi-random order, such that neither
condition was presented for more than two consecutive sessions.

Drug

discrimination training involved a two-lever operant task under a fixed ratio
20 (FR20) schedule of food pellet delivery. Twenty-minute training sessions
were conducted five - six days per week at approximately the same time each
day (8:00 am -10:00 am).

The criterion for discrimination was set at a

minimum of 80% correct lever responses before the first reinforcer of each
training session for at least nine out of ten consecutive training sessions.
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Dose Response Tests
Cumulative dosing procedures were employed to confirm accurate
stimulus control. Once this criterion was met by the subjects, cumulative
dose response tests were administered with cocaine (0, 0.3, 1.0, 3.0, 10.0
mg/kg). Animals were administered the first injection (0 mg/kg) and after a
10 minute period they were placed in the operant chambers until the animal
made 20 consecutive responses or five minutes had expired. 20 consecutive
responses on either lever produced one 45 mg pellet food reinforcer. The
animals were then removed from the test chambers and administered a
second dose (0.30 mg/kg). Following another 10 minute period, they were
again placed into the testing chamber for a five minute period.

This

procedure was repeated with the third, fourth, and fifth doses (cumulatively
equaling 10.0 mg/kg). This dosing procedure was administered on two
separate occasions, once following a drug training day and once following a
saline training day. In addition, a stimulus generalization test was
administered with MP (1.0-8.0 mg/kg). Half of the subjects were tested
following a cocaine training day, and half of the subjects were tested after a
saline training day. Training sessions were conducted on the days between
tests.

Data Analysis
The number of sessions to criterion was calculated and a between
group comparison was made. Data obtained from, two subjects (one saline
pretreated, and one MP pretreated) were not included in the analysis due to
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the requirement for individually tailored discrimination training that was not
consistent with the other subjects. Analysis of the percent correct during the
first FR and the percentage of total responses on the drug appropriate lever
across training sessions were compared between groups and a linear
regression analysis was conducted on the slope and elevation.

A between

group analysis of latency to complete the first FR was also conducted.
Cumulative dosing procedures with reinforced trials were used for
dose response tests. Test data from animals that did not complete the FR 20
requirement were not included in the data analysis of testing sessions. Two
way ANOVAs (group X dose) were conducted on results from each dose
response test. Dose response data were presented as the percent of total
responses made on the drug-appropriate lever during test sessions. 80% or
greater drug lever selection was considered evidence for stimulus
generalization. Response rate was presented as the number of responses
made on either lever per second during test sessions. For each dose tested,
the mean and the standard error of the mean were calculated. Two way
ANOVAs (group X dose) were conducted on each set of dose response data.
Statistical analysis were conducted using the software GraphPad Prism
(Version 2.0; GraphPad, Inc., San Diego, CA).
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RESULTS
Fourteen of the sixteen subjects readily acquired the discrimination
(minimum of 80% condition-appropriate responses prior to the delivery of
the first reinforcer in at least nine of ten consecutive training sessions) in the
present experiment.

One subject in each group required tailored

discrimination training. Surprisingly, pre-exposure to methylphenidate did
not appear to facilitate acquisition of the discrimination. In fact, the number
of sessions to criterion was slightly increased in the MP pretreated subjects
compared to the saline pretreated subjects. At-test on the number of sessions
to criterion was not statistically significant between the two groups (t=l.142,
df12, p=0.28). The mean of the MP pretreated group was 35.4 ± 2.4 (Range: 2647, n=7), and the mean of the control group was 31.6 ± 2.3 (Range: 26-44, n=7).
The results are displayed in Figure 1.
The measure of terminal accuracy for the percent correct lever choice
for the first fixed ratio illustrates considerable variability over the 69 training
sessions in both treatment groups. The total percent correct over training
sessions is also highly variable (Figure 2). This is also evident by examining
the individual subject variability plotted for both the MP pretreated group
and the saline pretreated group in Figures 3 and 4, respectively.
Visual analysis of the terminal accuracy data suggested that the MP
pretreated group might have a significantly lower accuracy over sessions.
Examination of the mean percent correct across sessions in which subjects
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responded below the established 80% drug appropriate lever criterion was
calculated for each group; the means were collapsed over sessions. The mean
for the MP pretreated group was 44.45 ± 3.5 (n=64, sessions below 80%) and
mean for the saline pretreated group was 45.49 ± 3.6 (n = 53, sessions below
80%). The difference between groups was not statistically significant,
according to a t-test on between groups number of sessions below criterion
(80%) (t= 0.206, df 115' p 837).

Sessions to Criterion
40
0
C

.2
30
0
0
C1)

u,

o 20
C1)

E
::::, 10

MP

SAL

Pre-exposure Treatment

Figure 1. Sessions to Criterion for Cocaine Discrimination.
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The latency to the first fixed ratio was examined, the means were
collapsed over sessions. The MP pretreated group took longer than the saline
pretreated group to successfully complete their first FR. The mean number of
seconds to the first FR for the MP pretreated group is 571.1 ± 113.9 and the
mean number of seconds for the saline pretreated group is 241.6 ± 78.01.
Statistical analysis indicates that the means are significantly different (t=2.39,
df941 p=0.01, see Figure 5).
Concern regarding the use of reinforced trials during the cumulative
dosing procedure motivated the implementation of a trial procedure. Our
concern was that the animals would continue to respond on the lever that
produced the reinforcer on the previous trial. This was not the case, as
evident by the data presented in Figure 6. Sixteen rats were randomly
divided into three groups. Each group received the training dose of cocaine at
a different stage of the cumulative dose procedure. This was done to assure
that accurate stimulus control was maintained during repeated dosing
procedures.

Latency to First FR

� 1000

.5

Q)

.E soo

....

o......___...______.__----'-"==="-"--_____.
Saline pre-exposure

MP pre-exposure

Pre-exposure groups

Figure 5. Results of Latency to First FR Between Groups.
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Figure 6a illustrates the results of tests when cocaine was introduced in
the second phase, 6b when cocaine was introduced in the third phase, and
Figure 6c when cocaine was introduced in the fourth phase. In each case the
subjects respond appropriately, switching from the saline- appropriate lever
to the cocaine-appropriate lever when cocaine was introduced.

The

introduction of drug reliably produced greater than 80% responding on the
drug appropriate lever. This trial procedure was conducted three times and
subjects were systematically exposed to all three trial phases.
Following the determination that the commutative dosing procedure
produced reliable results, training was resumed for two sessions, one saline
treatment day and one cocaine treatment day.

Cumulative dosing

procedures were then implemented to conduct stimulus generalization tests
with cocaine (0, 0.3, 1.0, 3.0, 10.0 mg/kg). Testing was first conducted after a
drug training day (Figure 7), and then after a saline training day (Figure 8).
The rate of responding was not significantly decreased in a dose-dependent
fashion. There was a significant dose effect in both tests (Figure 7, F = 8.59, df
4,

so, p < 0.0001; Figure 8, F= 8.52, df

4, 47,

p<0.0001). There was no significant

effect of pre-exposure in the cocaine dose-response curve following cocaine
training day (F = 0.01, df1,501 p = 0.94); nor was there a significant pretreatment
effect on the cocaine dose-response curve following a saline training day (F
=0.88, df 1, 47, p=0.35). There was no significant interaction between dose and
treatment in either dose response curve.
Methylphenidate

substitution

tests

were

conducted.

Stimulus

generalization with MP revealed similar dose response curves in both groups
(Figure 9). Full substitution was apparent at doses of 4.0 mg/kg and 8.0
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mg/kg in both groups. There was a significant dose-dependent decrease in
response rate (F=8.59, df 4,so, p<0.0001) and there were no significant treatment
effects on response rate (F=0.01, df

1, 50,

p=0.94) nor were there significant

interaction effects (F=0.57, df 4,50, p= 0.68). The ED50's for the treatment groups
were 2.22 mg/kg for the MP pretreated group and 2.0 mg/kg for the saline
pretreated group.

Cummulatlve Dose Test Trlals
Figure 6a
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DISCUSSION
The primary goal of the present study was to assess if
methylphenidate would affect the stimulus properties of cocaine. Results
indicate that exposure to 10 mg/kg methylphenidate for five consecutive
days did not produce marked effects on the acquisition of a cocaine
discrimination. There was no significant difference in the number of sessions
to criterion between groups. This suggests that MP pretreatment did not
significantly affect the acquisition of cocaine discrimination. In fact, contrary
to the anticipated outcome, the MP pretreated group appeared slightly
slower to acquire cocaine discrimination. In light of the fact that stimulant
exposure is reported to enhance the acquisition of cocaine self-administration
(Horger, Shelton and Schenk, 1990), this may suggest that the subjective
effects of drugs require a more rigorous pretreatment period.
Although this trend was not statistically significant, all analyses in the
present study support the theory that MP pretreated group tended to be less
accurate than the saline pretreated group. The MP pretreated group express
lower rates of accuracy, and significantly longer latencies to the first FR. A
linear regression of first FR data across all training sessions indicates the MP
treated animals exhibited lower terminal accuracy. The results of this study
suggest that MP exposure may have effects on learning, however further
investigation is needed to ascertain what those effects are. A continuation of
the present study may examine the effects of a similar exposure procedure on
a memory task such as maze learning.
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Both treatment groups exhibited similar cocaine and methylphenidate

dose-response functions. The MP pretreated group did not express an
enhanced response to the low doses of cocaine nor did the exposure
significantly

shift

the

methylphenidate

dose

response

function.

Methylphenidate did fully substituted at doses of 4.0 mg/kg and 8.0 mg/kg
for the training-dose (10 mg/kg) of cocaine. This is consistent with previous
research

indicating

a

similarity

between

the

stimulus

cues

of

methylphenidate and cocaine (Dackis and Gold, 1990; Volkow et al., 1995).
The secondary goal of this study was to examine the use of drug
discrimination as a tool for studying sensitization. We established the ground
work for examining drug discrimination as a tool for measuring effects of
drug history on performance. Although the pretreatment did not significantly
enhance the subjective drug experience, perhaps future investigations will
examine the effects of chronic stimulant treatment on the dose-response
function.
There were procedural issues that are inherent to the drug
discrimination procedure, which made a between groups study difficult to
tailor for individual subjects. Because MP treatment was the crucial variable
in the study, all discrimination training had to be identical between groups
for any reliable statement to be made regarding history. For such studies to
be valid, it is essential that they hold constant the current environmental
circumstances at the time. As noted in the results, two subjects required a
reduced FR following the treatment. Therefore, they were not used in the
analysis of sessions to criterion.
Another possible limitation of the drug discrimination assays is the
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length of time it takes for subjects to achieve reliable responding. During the
training period, subjects received the training drug, 10 mg/kg cocaine up to
three days per week.

It may be that the training procedures have an

interactive effect with the pretreatment, diminishing the effect of the
sensitization, and perhaps inducing tolerance.
The clinical relavance of this experiment is difficult to interpret. Since
pretreatment did not affect the dose response function, it can be concluded
that either the pretreatment did not produce adequate sensitization to shift
the curve to the left, or that sensitization does not enhance the subjective
effects of cocaine. A follow-up study might increase the duration of the
pretreatment phase, and test for cross-sensitization to the locomotor effects of
cocaine prior to the discrimination training.
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Appendix A
Protocol Clearance From the Institutional Animal Care and Use Committee
(IACUC)

WESTERN MICHIGAN UNIVERSITY
INVESTIGATOR IACUC CERTIFICATE

29

Title of Project: Assessment of Methylphenidate Sensitization Using a Drug Discrimination
Procedure
The information included in this IACUC application is accurate to the best of my knowledge. All
personnel listed recognize their responsibility in complying with university policies governing the
care and use of animals.
I declare that all experiments involving live animals will be performed under my supervision or
that of another qualified scientist. Technicians or students involved have been trained in proper
procedures in animal handling, administration of anesthetics, analgesics, and euthanasia to be used
in this project.
If this project is funded by an extramural source, I certify that this application accurately reflects
all procedures involving laboratory animal subjects described in the proposal to the funding
agency noted above.
Any proposed revisions to or variations from the animal care and use data will be promptly
forwarded to the IACUC for approval.
___ Disapproved

___ Approved

�pproved with the provisions listed below

Date 1 ,

hairp erson Final Approval
ved IACUC Number 9.9 -G? -02,.
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